Brown, Theodore R., M.D., MPH Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00457730
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

dalfampridine (ampyra) (1 trial)

Drugs in Phase 3 Trials (1)

duloxetine (Cymbalta) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Sclerosis (Phase 4)

Sclerosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2